InspireMD's MGuard Stent Shows Lower Mortality Rate in STEMI Patients at Twelve Months Compared to Control Group

Company to Host Conference Call Tomorrow at 5:30 a.m. PT / 8:30 a.m. ET

Oct 29, 2013, 16:23 ET from InspireMD

$countyNameToPathMap.put("sp